Creatine supplementation reduces muscle inosine monophosphate during endurance exercise in humans. 2005

Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
Department of Physiology, Monash University, Clayton, Victoria, AUSTRALIA.

BACKGROUND Creatine (Cr) supplementation has been shown to attenuate increases in plasma ammonia and hypoxanthine during intense endurance exercise lasting 1 h, suggesting that Cr supplementation may improve muscle energy balance (matching of ATP resynthesis to ATP demand) during such exercise. We hypothesized that Cr supplementation would improve muscle energy balance (as assessed by muscle inosine monophosphate (IMP) accumulation) during intense endurance exercise. METHODS Seven well-trained men completed two experimental trials involving approximately 1 h of intense endurance exercise (cycling 45 min at 78+/-1% & OV0312;O2 peak followed by completion of 251+/-6 kJ as quickly as possible (performance ride)). Subjects ingested approximately 42 g.d dextrose for 5 d before the first experimental trial (CON), then approximately 21 g Cr monohydrate plus approximately 21 g.d dextrose for 5 d before the second experimental trial (CREAT). Trials were ordered because of the long washout time for Cr. Subjects were blinded to the order of the trials. RESULTS Creatine supplementation significantly (P< 0.05) increased muscle total Cr (resting values: CREAT: 138.1+/-7.9; CON: 117.7+/- 6.5 mmol.kg dm). No difference was seen between treatments in any measured muscle or blood metabolite after the first 45 min of exercise. Despite the performance ride completion time being similar in the two treatments ( approximately 13.5 min, approximately 86% & OV0312;O2 peak), IMP at the end of the performance ride was significantly (P<0.05) lower in CREAT than in CON (CREAT: 1.2+/- 0.6; CON: 2.0+/- 0.7 mmol.kg dm). CONCLUSIONS Raising muscle total Cr content before exercise appears to improve the ability of the muscle to maintain energy balance during intense aerobic exercise, but not during more moderate exercise intensities.

UI MeSH Term Description Entries
D007291 Inosine Monophosphate Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. IMP,Inosinic Acid,Ribosylhypoxanthine Monophosphate,Inosinic Acids,Sodium Inosinate,Acid, Inosinic,Acids, Inosinic,Inosinate, Sodium,Monophosphate, Inosine,Monophosphate, Ribosylhypoxanthine
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D017079 Exercise Tolerance The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST. Tolerance, Exercise

Related Publications

Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
November 1996, The American journal of physiology,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
April 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
October 1998, Journal of applied physiology (Bethesda, Md. : 1985),
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
June 1989, Acta physiologica Scandinavica,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
August 2004, International journal of sport nutrition and exercise metabolism,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
February 1990, The Physiologist,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
April 1999, European journal of applied physiology and occupational physiology,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
July 1998, Medicine and science in sports and exercise,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
December 1993, Acta physiologica Scandinavica,
Glenn K McConell, and Joanna Shinewell, and Terry J Stephens, and Christos G Stathis, and Benedict J Canny, and Rodney J Snow
January 2021, Nature metabolism,
Copied contents to your clipboard!